Potential roles of growth factor PDGF-BB in the bony repair of injured growth plate

Bone

Volumn 44, Issue 5, 2009, Pages 878-885

  Chung, Rosa ^a,b,c   Foster, Bruce K ^a   Zannettino, Andrew C W ^d   Xian, Cory J ^a,b,c  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^d INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Bone marrow stromal cells; Growth plate; Imatinib; Injury and repair; PDGF BB

Indexed keywords

GROWTH FACTOR; IMATINIB; PLATELET DERIVED GROWTH FACTOR BB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE GROWTH; BONE INJURY; BONE REMODELING; CELL MIGRATION; CONTROLLED STUDY; FIBROGENESIS; GROWTH PLATE; MALE; MESENCHYME CELL; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN TYPE II; GENE EXPRESSION; GROWTH PLATE; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELLS; OSTEOCALCIN; OSTEOCLASTS; PIPERAZINES; PLATELET-DERIVED GROWTH FACTOR; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS;

EID: 63449134564     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.01.377     Document Type: Article

References (33)

1. Ando W., Hashimoto J., Nampei A., Tsuboi H., Tateishi K., Ono T., et al. Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA). J. Bone Miner. Metab. 24 (2006) 274-282
2. Andrae J., Gallini R., and Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 22 (2008) 1276-1312
3. Arasapam G., Scherer M., Cool J.C., Foster B.K., and Xian C.J. Roles of COX-2 and iNOS in the bony repair of the injured growth plate cartilage. J. Cell. Biochem. 99 (2006) 450-461
4. Ball S.G., Shuttleworth C.A., and Kielty C.M. Platelet-derived growth factor receptor-alpha is a key determinant of smooth muscle alpha-actin filaments in bone marrow-derived mesenchymal stem cells. Int. J. Biochem. Cell Biol. 39 (2007) 379-391
5. Board R., and Jayson G.C. Platelet-derived growth factor receptor (PDGFR): a target for anticancer therapeutics. Drug Resist. Updat. 8 (2005) 75-83
6. Bonner J.C. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 15 (2004) 255-273
7. Cho T.J., Gerstenfeld L.C., and Einhorn T.A. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J. Bone Miner. Res. 17 (2002) 513-520
8. Chung R., Cool J.C., Scherer M.A., Foster B.K., and Xian C.J. Roles of neutrophil-mediated inflammatory response in the bony repair of injured growth plate cartilage in young rats. J. Leukoc. Biol. 80 (2006) 1272-1280
9. Cospedal R., Abedi H., and Zachary I. Platelet-derived growth factor-BB (PDGF-BB) regulation of migration and focal adhesion kinase phosphorylation in rabbit aortic vascular smooth muscle cells: roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinases. Cardiovasc. Res. 41 (1999) 708-721
10. Dewar A., Zannettino A.C.W., Hughes T.P., and Lyons A.B. Inhibition of c-fms by imatinib - expanding the spectrum of treatment. Cell Cycle 4 (2005) 851-853
11. Dewar A.L., Cambareri A.C., Zannettino A.C., Miller B.L., Doherty K.V., Hughes T.P., et al. Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. Blood 105 (2005) 3127-3132
12. Dewar A.L., Farrugia A.N., Condina M.R., Bik To L., Hughes T.P., Vernon-Roberts B., et al. Imatinib as a potential antiresorptive therapy for bone disease. Blood 107 (2006) 4334-4337
13. El Hajj Dib I., Gallet M., Mentaverri R., Sevenet N., Brazier M., and Kamel S. Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity. Eur. J. Pharmacol. 551 (2006) 27-33
14. Fiedler J., Etzel N., and Brenner R.E. To go or not to go: migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J. Cell. Biochem. 93 (2004) 990-998
15. Fiedler J., Roderer G., Gunther K.P., and Brenner R.E. BMP-2, BMP-4 and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J. Cell. Biochem. 87 (2002) 305-312
16. Fierro F., Illmer T., Jing D., Schleyer E., Ehninger G., Boxberger S., et al. Inhibition of platelet-derived growth factor receptorbeta by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro. Cell Prolif. 40 (2007) 355-366
17. Fitter S., Dewar A.L., Kostakis P., To L.B., Hughes T.P., Roberts M.M., et al. Long-term imatinib therapy promotes bone formation in CML patients. Blood 111 (2008) 2538-2547
18. Grey A., O'Sullivan S., Reid I.R., and Browett P. Imatinib mesylate, increased bone formation, and secondary hyperparathyroidism. N. Engl. J. Med. 355 (2006) 2494-2495
19. Heldin C.H. Platelet-derived growth factor-an introduction. Cytokine Growth Factor Rev. 15 (2004) 195-196
20. Hollinger J.O., Hart C.E., Hirsch S.N., Lynch S., and Friedlaender G.E. Recombinant human platelet-derived growth factor: biology and clinical applications. J. Bone Joint Surg., Am. 90 Suppl 1 (2008) 48-54
21. Hollinger J.O., Hart C.E., Hirsch S.N., Lynch S., and Friedlaender G.E. Clinical applications recombinant human platelet-derived growth factor: biology and clinical applications. J. Bone Joint. Surg., Am. 90 (2008) 48-54
22. Hwang R.F., Yokoi K., Bucana C.D., Tsan R., Killion J.J., Evans D.B., et al. Inhibition of platelet-derived growth factor receptor phosphorylation by ST1571 (Gleevec) reduced growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. Clin. Cancer Res. 9 (2003) 6534-6544
23. Mishima Y., and Lotz M. Chemotaxis of human articular chondrocytes and mesenchymal stem cells. J. Orthop. Res. 26 (2008) 1407-1412
24. Ngo T.Q., Scherer M.A., Zhou F.H., Foster B.K., and Xian C.J. Expression of bone morphogenic proteins and receptors at the injured growth plate cartilage in young rats. J. Histochem. Cytochem. 54 (2006) 945-954
25. O'Sullivan S., Naot D., Callon K., Porteous F., Horne A., Wattie D., et al. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms. J. Bone Miner. Res. 22 (2007) 1679-1689
26. Ozaki Y., Nishimura M., Sekiya K., Suehiro F., Kanawa M., Nikawa H., et al. Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cell Dev. 16 (2007) 119-129
27. Rajkumar V.S., Shiwen X., Bostrom M., Leoni P., Muddle J., Ivarsson M., et al. Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am. J. Pathol. 169 (2006) 2254-2265
28. Tatsuyama K., Maezawa Y., Baba H., Imamura Y., and Fukuda M. Expression of various growth factors for cell proliferation and cytodifferentiation during fracture repair. Eur. J. Histochem. 44 (2000) 269-278
29. Xian C.J. Roles of epidermal growth factor family in the regulation of postnatal somatic growth. Endocr. Rev. 28 (2007) 284-296
30. Xian C.J., and Foster B.K. The biological aspects of children's fractures. In: Beaty J., and Kasser J. (Eds). Fractures in children (2006), Lippincott Williams and Wilkins, Philadephia 21-50
31. Xian C.J., Zhou F.H., McCarty R.C., and Foster B.K. Intramembranous ossification mechanism for bone bridge formation at the growth plate cartilage injury site. J. Orthop. Res. 22 (2004) 417-426
32. Zhou F.H., Foster B.K., Zhou X.F., Cowin A.J., and Xian C.J. TNF-alpha mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats. J. Bone Miner. Res. 21 (2006) 1075-1088
33. Zhou F.H., Foster B.K., Sander G., and Xian C.J. Expression of proinflammatory cytokines and growth factors at the injured growth plate cartilage in young rats. Bone 35 (2004) 1307-1315